On this page
FBXL4
F-box and leucine rich repeat protein 4
The FBXL4 gene provides instructions for a protein essential for mitochondrial function, with variants linked to a severe neurodevelopmental condition. The FBXL4 gene encodes a protein involved in maintaining mitochondrial DNA, which is crucial for cellular energy production.
FBXL4 is located on the long (q) arm of chromosome 6, at band 6q16.1-q16.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 6 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The FBXL4 gene, or F-box and leucine rich repeat protein 4, is integral to the normal functioning of mitochondria within human cells. Mitochondria are vital cellular components responsible for energy production, signalling, and regulating cell growth and death. The protein produced from the FBXL4 gene is thought to be involved in the maintenance of mitochondrial DNA (mtDNA), which is essential for these processes.
What the gene does
The FBXL4 gene directs the synthesis of a protein that belongs to the F-box and leucine-rich repeat protein family. This FBXL4 protein forms part of a larger protein complex located within mitochondria. In this complex, FBXL4 likely contributes to the maintenance of mitochondrial DNA. Adequate levels of mtDNA are critical for efficient cellular energy production. Dysfunction in this role can disrupt mitochondrial processes, leading to significant health issues.
Video: Genetics 101
Chromosome location
The FBXL4 gene is located on chromosome 6, specifically within the 6q16.1-q16.2 region. This chromosomal band position helps geneticists pinpoint the gene's precise location on the long arm (q arm) of chromosome 6.
Protein structure
The FBXL4 protein consists of 621 amino acids and features several distinct domains. It contains an F-box domain located between amino acids 277 and 332. Additionally, the protein includes nine Leucine-rich repeat (LRR) regions: LRR 1 (amino acids 376-397), LRR 2 (amino acids 402-421), LRR 3 (amino acids 427-448), LRR 4 (amino acids 452-474), LRR 5 (amino acids 480-501), LRR 6 (amino acids 504-524), LRR 7 (amino acids 532-558), LRR 8 (amino acids 559-583), and LRR 9 (amino acids 584-609).
Key variants
Variants in the FBXL4 gene can impact the protein's ability to maintain mitochondrial DNA, leading to disrupted cellular energy production. Over 47 different genetic changes have been identified in this gene, each potentially altering the protein's structure or function and contributing to associated conditions.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1067del | p.Gly356fs | Pathogenic | ★★☆☆ | Mitochondrial DNA depletion syndrome 13 |
c.1288C>T | p.Arg430Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Mitochondrial DNA depletion syndrome 13 |
c.141del | p.Asn48fs | Pathogenic | ★★☆☆ | Mitochondrial DNA depletion syndrome 13 |
c.1648_1649del | p.Asp550fs | Pathogenic | ★★☆☆ | Mitochondrial DNA depletion syndrome 13 |
c.370C>T | p.Gln124Ter | Pathogenic/Likely pathogenic | ★★☆☆ | FBXL4-related disorder |
c.486T>A | p.Tyr162Ter | Pathogenic | ★★☆☆ | Mitochondrial DNA depletion syndrome 13 |
c.616C>T | p.Arg206Ter | Pathogenic/Likely pathogenic | ★★☆☆ | FBXL4-related disorder |
c.627_633del | p.Asn210fs | Pathogenic | ★★☆☆ | Mitochondrial DNA depletion syndrome 13 |
c.827del | p.Asn276fs | Pathogenic | ★★☆☆ | Inborn genetic diseases |
c.859-1G>T | - | Pathogenic/Likely pathogenic | ★★☆☆ | Mitochondrial DNA depletion syndrome 13 |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the FBXL4 gene are primarily associated with FBXL4-related encephalomyopathic mitochondrial DNA depletion syndrome. This condition affects multiple body systems and is characterised by brain dysfunction combined with muscle weakness (encephalomyopathy). It is frequently severe, often proving fatal during early childhood. Additionally, variants in FBXL4 have been linked to Leigh syndrome.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
UK clinical status
The FBXL4 gene is recognised in the UK for its association with several conditions and is included on multiple NHS Genomic Medicine Service clinical panels. These include panels for Ataxia and cerebellar anomalies - childhood onset, Developmental Disorders Gene (DDG2P), Early onset or syndromic epilepsy, Foetal anomalies (R21), Intellectual disability, Likely inborn error of metabolism (R98), Mitochondrial disorders, Mitochondrial DNA maintenance disorder (R352), Paediatric or syndromic cardiomyopathy (R135), Possible mitochondrial disorder, nuclear genes (R63), Pyruvate dehydrogenase (PDH) deficiency (R316), and Undiagnosed metabolic disorders.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary function of the FBXL4 gene?
The FBXL4 gene provides instructions for a protein that is a component of a larger protein complex within mitochondria. This complex is believed to be important for the maintenance of mitochondrial DNA, which is essential for cellular energy production.
Which conditions are associated with variants in the FBXL4 gene?
Variants in the FBXL4 gene are primarily associated with FBXL4-related encephalomyopathic mitochondrial DNA depletion syndrome, a severe condition affecting the brain and muscles. It has also been linked to Leigh syndrome.
How does FBXL4 relate to mitochondrial health?
The FBXL4 protein is located within the mitochondria and plays a role in ensuring adequate levels of mitochondrial DNA (mtDNA). Proper mtDNA maintenance is critical for the mitochondria to produce energy efficiently, supporting overall cellular health.
References
- Dai H, Zhang VW, El-Hattab AW. FBXL4 defects are common in patients with congenital lactic acidemia and encephalomyopathic mitochondrial DNA depletion syndrome. Clinical genetics. 2017. PMID: 27743463
- Bonnen PE, Yarham JW, Besse A. Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance. American journal of human genetics. 2013. PMID: 23993193
- Gai X, Ghezzi D, Johnson MA. Mutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathy. American journal of human genetics. 2013. PMID: 23993194
- Adam MP, Bick S, Mirzaa GM. FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome. 1993. PMID: 28383868